查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1847711

電腦輔助檢測市場按部署方式、最終用戶、組件、顯像模式和應用分類－2025-2032年全球預測

Computer Aided Detection Market by Deployment, End User, Component, Imaging Modality, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，電腦輔助檢測市場將成長至 34.2737 億美元，複合年成長率為 16.69%。

主要市場統計數據
基準年 2024 9.965億美元
預計年份：2025年 11.6168億美元
預測年份：2032年 3,427,370,000 美元
複合年成長率 (%) 16.69%

本文概述了演算法檢測在臨床影像中不斷演變的作用，以及推動其在醫療保健服務環境中廣泛應用的策略促進因素。

電腦輔助檢測已從實驗室輔助手段發展成為提高診斷效率和臨床決策支援的核心推動力。過去十年間，醫學影像硬體和軟體演算法的進步，使自動檢測從一種小眾研究工具發展成為診斷中心、醫院和實驗室的常用操作能力。隨著影像吞吐量和成像方式的日益多樣化，醫療專業人員擴大借助演算法輔助來縮短閱片時間、識別細微病變，並在分散的醫療環境中實現影像判讀的標準化。

這種應用模式勾勒出現代格局，其中部署選擇、臨床工作流程整合以及監管環境的接受程度決定了檢測工具從診斷到常規應用的轉變速度。它還有助於理解基礎設施偏好（無論是提供可管理擴展性的雲端平台，還是優先考慮資料駐留的本地系統）如何影響採購和供應商選擇。透過強調演算法演進、顯像模式覆蓋範圍以及從腫瘤學到常規篩檢的臨床應用案例之間的相互關係，這種應用模式為決策者指明了推動應用和持續價值實現的策略槓桿。

了解正在重新定義發現軟體如何融入臨床護理和採購的關鍵技術、監管和商業性曲折點。

電腦輔助檢測領域正經歷著變革性的轉變，其驅動力包括技術的成熟、醫療服務模式的轉變以及監管期望的演變。首先，深度學習加速了演算法的複雜化，使得在CT和MRI等複雜成像模式下實現更精細的模式識別成為可能。雲端平台為回顧性訓練和前瞻性推理提供了彈性運算能力，而混合部署和本地部署在資料主權和延遲限制至關重要的場景下仍然具有吸引力。

同時，臨床應用正受到報銷和價值考量的推動，這些考慮將檢測性能與可衡量的工作流程改進和患者預後聯繫起來。放射科團隊和腫瘤中心越來越重視解決方案的整合便捷性、解讀便捷性以及對重症病例進行分診的能力。最後，為了滿足市場對可嵌入電子健康記錄和PACS環境的端到端解決方案的需求，供應商的策略正圍繞著將影像處理演算法與臨床決策支援和連接性相結合的綜合產品套件進行整合。這些轉變強調整合性、臨床檢驗和營運可擴展性是未來成功的關鍵決定因素。

了解近期關稅和貿易動態如何重塑採購邏輯、供應商策略以及對模組化、互通解決方案的重視程度。

近期關稅和貿易政策的變動為影像處理硬體和運算基礎設施的採購和供應鏈規劃帶來了新的變數。對於依賴進口影像檢測器、專用處理器或預先配置推理設備的系統而言，進口關稅的提高會增加整體擁有成本並延長供應商的前置作業時間。因此，採購團隊正在重新評估供應商，更加重視模組化和在地採購選項，同時仔細審查服務合約中保護買方免受供應鏈不穩定影響的條款。

除了直接的設備成本外，關稅還會影響供應商的定價策略和策略性在地化決策。一些供應商正透過多元化製造地或與區域整合商合作來應對，以保持價格競爭力並維持服務水準。另一些供應商則透過放棄硬體捆綁銷售、加快推出純軟體產品來最大限度地降低跨境關稅的影響。同時，用戶正在優先考慮雲端原生部署和訂閱授權模式，這種模式將授權與硬體採購週期脫鉤。最終結果是，人們更加重視合約的靈活性，並重新強調互通性，從而使醫療服務提供者能夠在不產生過高成本或影響臨床連續性的情況下更換組件。

明確部署模式、最終使用者畫像、組件差異、顯像模式和臨床應用如何決定開發和商業化優先順序。

了解市場區隔有助於明確產品設計和商業化工作必須如何與使用者需求和技術限制相符。部署選項分為雲端和本地部署管道，其中雲端產品又根據平台服務和軟體即服務 (SaaS) 進一步細分，而本地部署系統則根據永久授權和訂閱模式進行區分。最終使用者細分涵蓋診斷中心、醫院和實驗室，每個機構的工作流程量和檢驗要求各不相同。在醫院中，腫瘤科和放射科尤其重要，這些科室需要精準的檢測能力以及與多環節工作流程的整合。

組件細分將硬體、服務和軟體分開。在軟體方面，重點在於演算法效能，深度學習、傳統機器學習和基於規則的方法在可解釋性、訓練資料需求和泛化能力方面各有優劣。顯像模式細分突顯了CT、MRI、PET、超音波和X光等成像模式的獨特需求，這些模式在解析度、造影機制和成像方式上的差異，對演算法設計和檢驗方法提出了不同的要求。最後，應用細分（包括乳腺癌、大腸直腸癌、肺癌和前列腺癌檢測）突顯了應用場景的臨床異質性。這些細分共同為供應商指明了工程研發、臨床證據產生和市場推廣策略的優先順序。

了解美洲、歐洲、中東和非洲以及亞太地區在監管、採購和臨床方面的差異如何影響商業化和部署選擇。

區域動態對產品採納模式、監管管道和商業策略有顯著影響。在美洲，醫療系統和私人影像網路傾向於快速採用檢驗的檢測工具，這些工具能夠展現工作流程效率並與電子病歷系統無縫整合；同時，採購團隊會密切評估與報銷管道和臨床醫生工作效率相關的提案。相較之下，歐洲、中東和非洲的監管環境則較為複雜，各國衛生監管機構的要求和資料駐留規則使得企業需要採用更為精細的市場推廣模式。供應商通常會尋求與當地整合商建立策略夥伴關係，並優先考慮與區域臨床指南保持一致。

亞太地區龐大的影像處理需求以及公共混合的交付模式，為可擴展的雲端部署或本地託管解決方案提供了機遇，以滿足監管和基礎設施方面的限制。在所有地區，成功的關鍵在於根據當地患者群體客製化檢驗研究，確保語言和工作流程的在地化，並建立支援大規模部署的服務能力。從先導計畫過渡到企業級部署，既需要技術適應能力，也需要對每個地區的採購習慣和臨床重點有深刻的理解。

摘要了競爭格局，其中臨床檢驗、整合能力和卓越服務決定了供應商的差異化和買家的選擇。

競爭動態將取決於那些能夠證明其產品已通過臨床檢驗、具備強大的整合能力並能清楚展現營運價值的公司。領先的供應商通常會將演算法方面的專業知識與和影像處理硬體製造商、PACS供應商以及醫療IT整合商建立的牢固夥伴關係相結合，從而降低實施過程中的阻力。此外，那些提供實施支援、臨床醫生培訓和績效監控等服務的參與企業，透過確保持續的臨床應用和可衡量的工作流程改進，在初始授權合約到期後仍能保持客戶的黏著度。

新參與企業透過專注於特定應用和模式，並利用專有資料集和學術合作來建立差異化演算法，從而展開競爭。同時，成熟的影像處理供應商和雲端服務供應商正利用其規模和平台能力，提供吸引企業買家的捆綁式解決方案。策略聯盟和收購持續影響著這一競爭格局，大型公司尋求填補模式和應用方面的空白，而小型公司則尋求與領先的臨床中心建立檢驗夥伴關係以提升信譽。對於買家而言，選擇供應商越來越受到評估的驅動，這些評估不僅包括檢測準確性，還包括售後支援、法規遵循以及共同開發客製化工作流程的能力。

向供應商和醫療機構推薦具體的策略重點，以加速產品應用、確保互通性並展現持久的臨床和營運價值。

行業領導者應優先採取一系列切實可行的舉措，將循證實踐與應用推廣和持續價值聯繫起來。首先，透過投資進行與支付方和醫療服務提供方採購委員會關注的終點指標相符的、嚴謹的臨床檢驗研究，將技術績效轉化為可量化的臨床和營運效益。其次，採用模組化架構，使軟體能夠在雲端、混合雲端和本地環境中運行，從而滿足不同客戶的需求，並降低供應鏈和關稅的影響。

第三，與影像處理硬體供應商、IT整合商和臨床中心建立牢固的夥伴關係關係，以加速技術應用並降低實施風險。第四，設計能夠反映實際營運的定價和合約方案，例如按使用量付費的訂閱模式或基於結果的交付模式，以降低技術應用門檻。最後，建立性能監控、臨床醫生反饋機制以及部署後持續學習能力，以保持演算法的有效性並展現其長期價值。透過實施這些建議，企業領導者可以將技術創新轉化為持續的市場優勢和更深入的臨床整合。

詳細介紹了一種透明的混合方法研究途徑，該方法整合了相關人員訪談、臨床文獻和產品文檔，以使建議能夠立足於實際操作層面。

研究途徑結合了多學科依證和結構化的定性綜合分析，以確保得出穩健且可操作的結論。透過對設備採購人員、放射科主任、影像技師和演算法開發人員的結構化訪談，我們獲得了關於部署偏好、檢驗預期和操作痛點的觀點。次要分析綜合了關於演算法性能和特定成像方式技術限制的同行評審文獻，並輔以監管指導文件和公開的臨床試驗註冊數據，以評估證據基礎的成熟度。

我們的調查方法著重於三角驗證，將供應商的能力聲明和產品文件與臨床醫生的回饋和用例進行比對，以識別實施方面的差距。在適當情況下，我們參考了技術白皮書和互通性規範，以檢驗有關整合和資料處理的說法。在整個研究過程中，我們強調可重複性和透明度，記錄了受訪相關人員的納入標準、適用模式和用途的範圍，以及在缺乏公開證據的情況下推斷的局限性。這種混合方法確保了建議既反映了實際操作情況，也符合科學檢驗的現狀。

最後，從綜合角度探討臨床檢驗、互通性和適應性商業模式將如何決定檢測解決方案的長期成功。

總之，電腦輔助檢測融合了演算法進步、臨床對可靠決策支援的需求，以及商業模式向靈活性和可驗證價值傾斜的轉變。其應用取決於供應商能否將演算法效能與無縫整合、可重複的臨床證據以及符合當地監管和採購實際情況的靈活部署方案相結合。因此，決策者應從臨床有效性、部署靈活性和上市後支援等多個方面評估解決方案，以確保其持續發揮作用。

能夠將技術精準性與工作流程效率、診斷一致性和患者療效等方面的可衡量改進聯繫起來，並輔以降低准入門檻的定價和合約模式的供應商和服務商，將成為最終的贏家。透過將產品開發與專業用戶、影像方式和當地醫療保健系統的細微需求相結合，相關人員可以充分發揮檢測技術的優勢，並將其融入現代診斷流程，使其成為值得信賴的組成部分。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 用於低劑量電腦斷層掃描系統中早期肺癌檢測的深度學習演算法
  • 整合基於雲端基礎的電腦輔助檢測平台以進行遠端放射學協作
  • 在醫療設備中實施邊緣運算解決方案，以實現即時影像分析
  • 利用合成資料和生成對抗網路來增強模型訓練資料集
  • 自主診斷軟體的新興報銷框架與監管管道
  • 緩解演算法偏見並確保人工智慧驅動的醫學影像工具公平性的策略
  • 與電腦輔助檢測供應商和電子健康記錄提供者夥伴關係，實現無縫的臨床工作流程整合

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 依部署方式分類的電腦輔助檢測市場

  • 雲
    • PaaS
    • SaaS
  • 本地部署
    • 永恆的
    • 訂閱

9. 按最終使用者分類的電腦輔助檢測市場

  • 診斷中心
  • 醫院
    • 腫瘤學
    • 放射科
  • 研究所

第10章 電腦輔助檢測市場（按組件分類）

  • 硬體
  • 服務
  • 軟體
    • 演算法
      • 深度學習
      • 機器學習
      • 基於規則

11. 依顯像模式的電腦輔助檢測市場

  • CT
  • MRI
  • PET
  • 超音波
  • X光

第12章 電腦輔助檢測市場依應用領域分類

  • 乳癌
  • 冒號
  • 肺
  • 攝護腺

第13章 電腦輔助偵測市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 電腦輔助檢測市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國電腦輔助檢測市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Hologic, Inc.
    • GE HealthCare Technologies, LLC
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Fujifilm Holdings Corporation
    • International Business Machines Corporation
    • iCAD, Inc.
    • Volpara Health Technologies Limited
    • ScreenPoint Medical BV
    • Lunit Inc.
Product Code: MRR-385067DD9C86

The Computer Aided Detection Market is projected to grow by USD 3,427.37 million at a CAGR of 16.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 996.50 million
Estimated Year [2025] USD 1,161.68 million
Forecast Year [2032] USD 3,427.37 million
CAGR (%) 16.69%

Introduce the evolving role of algorithmic detection in clinical imaging and outline strategic drivers shaping adoption across healthcare delivery settings

Computer aided detection has matured from an experimental adjunct to a central enabler of diagnostic efficiency and clinical decision support. Over the past decade, advances in medical imaging hardware and software algorithms have converged to elevate automated detection from a niche research tool into an operational capability across diagnostic centers, hospitals, and research laboratories. As imaging throughput and modality diversity expand, providers increasingly rely on algorithmic assistance to reduce reading times, flag subtle pathology, and standardize interpretation across distributed care settings.

This introduction frames the contemporary landscape in which deployment choices, clinical workflow integration, and regulatory acceptance determine the pace at which detection tools move from pilot to routine use. It also situates the reader to understand how infrastructure preferences-whether cloud platforms offering managed scalability or on-premise systems prioritizing data residency-shape procurement and vendor selection. By highlighting the interplay between algorithm evolution, imaging modality coverage, and clinical use cases from oncology to routine screening, the introduction orients decision-makers to the strategic levers that will drive adoption and sustained value realization.

Describe the pivotal technological, regulatory, and commercial inflection points that together are redefining how detection software integrates into clinical care and procurement

The landscape of computer aided detection is undergoing transformative shifts driven by technological maturation, changing care delivery economics, and evolving regulatory expectations. First, algorithmic sophistication has accelerated through deep learning, enabling more nuanced pattern recognition across complex modalities such as CT and MRI, while also improving robustness in chest radiography and ultrasound. Second, the deployment conversation has shifted: cloud platforms now promise elastic compute for retrospective training and prospective inference, while hybrid and on-premise deployments retain appeal where data sovereignty and latency constraints matter.

Concurrently, clinical adoption is being propelled by reimbursement and value arguments that tie detection performance to measurable workflow gains and patient outcomes. Radiology groups and oncology centers increasingly evaluate solutions on integration ease, interpretability, and ability to triage high-acuity cases. Finally, vendor strategies are consolidating around comprehensive product suites that couple imaging algorithms with clinical decision support and connectivity, reflecting a market that favors end-to-end solutions capable of embedding into electronic health records and PACS environments. Taken together, these shifts emphasize integration, clinical validation, and operational scalability as the primary determinants of success moving forward.

Explain how recent tariff influences and trade dynamics are reshaping procurement logic, vendor strategies, and the emphasis on modular, interoperable solutions

Recent policy actions around tariffs and trade measures have introduced new variables into procurement and supply chain planning for imaging hardware and compute infrastructure. For systems that rely on imported imaging detectors, specialized processors, or preconfigured inference appliances, increased import duties can raise total cost of ownership and extend vendor lead times. Consequently, procurement teams are recalibrating vendor evaluations to emphasize modularity and local sourcing options, while service agreements are being scrutinized for clauses that insulate buyers from supply chain volatility.

Beyond direct device costs, tariffs influence vendor pricing strategies and strategic localization decisions. Some vendors respond by diversifying manufacturing footprints or partnering with regional integrators to preserve price competitiveness and maintain service levels. Others accelerate software-only offerings that pivot away from bundled hardware sales, thereby minimizing exposure to cross-border levies. In parallel, users are prioritizing cloud-native deployments or subscription licensing that decouple licensing from hardware procurement cycles. The net effect is heightened attention to contractual flexibility and a renewed emphasis on interoperability, enabling healthcare providers to swap components without incurring prohibitive costs or losing clinical continuity.

Reveal how deployment models, end-user profiles, component distinctions, imaging modalities, and clinical applications together define development and commercialization priorities

Understanding segmentation illuminates where product design and commercialization efforts must align with user needs and technical constraints. Deployment choices split between cloud and on-premise pathways, with cloud offerings further differentiated by platform service and software as a service approaches, while on-premise systems distinguish between perpetual licensing and subscription models; this dichotomy drives distinct expectations around maintenance, update cadence, and total lifecycle costs. End-user segmentation spans diagnostic centers, hospitals, and research laboratories, each with differing workflow volumes and validation requirements, and within hospital settings there is a particular focus on oncology and radiology specialties that demand targeted detection capabilities and integration with multidisciplinary workflows.

Component segmentation separates hardware, services, and software, and within software the focus narrows to algorithmic performance where deep learning, traditional machine learning, and rule-based approaches offer different trade-offs in explainability, training data needs, and generalizability. Imaging modality segmentation highlights modality-specific requirements across CT, MRI, PET, ultrasound, and X-ray, where resolution, contrast mechanisms, and acquisition variability impose unique algorithm design and validation approaches. Finally, application segmentation that includes breast, colorectal, lung, and prostate detection underscores the clinical heterogeneity of use cases: screening programs emphasize sensitivity and throughput, while diagnostic workflows prioritize specificity and detailed lesion characterization. Taken together, these segment lenses guide where vendors should prioritize engineering effort, clinical evidence generation, and go-to-market narratives.

Articulate how geographic regulatory, procurement, and clinical practice differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape commercialization and deployment choices

Regional dynamics materially influence adoption patterns, regulatory pathways, and commercial tactics. In the Americas, health systems and private imaging networks tend to favor rapid adoption of validated detection tools that can demonstrate workflow efficiency and integration with electronic records, while procurement teams closely assess reimbursement pathways and value propositions tied to clinician productivity. In contrast, the Europe, Middle East & Africa region presents a heterogeneous regulatory landscape where national health authority requirements and data residency rules require nuanced market entry models; vendors often pursue strategic partnerships with local integrators and prioritize conformity with regional clinical guidelines.

The Asia-Pacific region combines high volume imaging demand with a mix of public and private delivery models, creating opportunities for scalable cloud deployments as well as locally hosted solutions to meet regulatory and infrastructure constraints. Across all regions, success hinges on tailoring validation studies to local patient populations, ensuring linguistic and workflow localization, and building services capabilities that support deployments at scale. Transitioning from pilot projects to enterprise-grade installations requires both technical adaptability and a deep understanding of each region's purchasing practices and clinical priorities.

Summarize the competitive landscape where clinical validation, integration prowess, and service excellence determine vendor differentiation and buyer selection

Competitive dynamics are anchored by companies that can demonstrate clinical validation, robust integration capabilities, and a clear pathway to operational value. Leading vendors often combine algorithmic expertise with strong partnerships across imaging hardware manufacturers, PACS vendors, and health IT integrators to reduce friction at deployment. Additionally, service-oriented players that offer implementation support, clinician training, and performance monitoring create stickiness beyond initial license agreements by ensuring sustained clinical adoption and measurable workflow improvements.

New entrants compete by focusing on niche applications or modality specialization, leveraging proprietary datasets and academic collaborations to build differentiated algorithms. At the same time, established imaging vendors and cloud providers leverage scale and platform capabilities to offer bundled solutions that appeal to enterprise buyers. Strategic alliances and acquisitions continue to shape the competitive field, as larger players seek to fill modality or application gaps while smaller firms pursue validation partnerships with leading clinical centers to build credibility. For buyers, vendor selection increasingly evaluates not only detection accuracy but also post-sales support, regulatory readiness, and the capacity to co-develop bespoke workflows.

Recommend concrete strategic priorities for vendors and provider organizations to accelerate adoption, ensure interoperability, and demonstrate enduring clinical and operational value

Industry leaders should prioritize a set of actionable moves that translate evidence into adoption and sustained value. First, invest in clinically rigorous validation studies that align with the endpoints that matter to payers and provider procurement committees, thereby converting technical performance into quantifiable clinical and operational benefits. Second, embrace modular architectures that allow software to operate across cloud, hybrid, and on-premise environments to meet diverse customer constraints and to mitigate supply chain and tariff exposure.

Third, develop robust partnership models with imaging hardware vendors, IT integrators, and clinical centers to accelerate deployments and reduce implementation risk. Fourth, design pricing and contracting approaches that reflect operational realities-such as subscription models tied to usage or outcome-based provisions-to lower adoption barriers. Finally, build post-deployment capabilities for performance monitoring, clinician feedback loops, and continuous learning to maintain algorithmic relevance and to demonstrate longitudinal value. By executing these recommendations, leaders can convert technical innovation into durable market advantage and deeper clinical integration.

Detail a transparent mixed methods research approach that integrates stakeholder interviews, clinical literature, and product documentation to ground recommendations in operational reality

The research approach combined a multi-disciplinary evidence base and a structured qualitative synthesis to ensure robust, actionable conclusions. Primary insights derived from structured interviews with device procurement leads, radiology chiefs, imaging technologists, and algorithm developers provided perspective on deployment preferences, validation expectations, and operational pain points. Secondary analysis integrated peer-reviewed literature on algorithm performance and modality-specific technical constraints, complemented by regulatory guidance documents and publicly available clinical trial registries to assess evidence maturity.

The methodology emphasized triangulation: vendor capability statements and product documentation were cross-checked against clinician feedback and case studies to reveal implementation gaps. Where appropriate, technical white papers and interoperability specifications were referenced to validate claims about integration and data handling. Throughout the research, attention centered on reproducibility and transparency, documenting inclusion criteria for interviewed stakeholders, the scope of modality and application coverage, and the limits of inference where public evidence was sparse. This mixed-methods approach ensured that recommendations reflect both operational realities and the state of scientific validation.

Conclude with an integrative perspective on how clinical validation, interoperability, and adaptive commercial models will determine long term success for detection solutions

In conclusion, computer aided detection is positioned at the confluence of algorithmic progress, clinical demand for reliable decision support, and shifting commercial models that prioritize flexibility and demonstrable value. Adoption will continue to hinge on the ability of vendors to pair algorithmic performance with seamless integration, reproducible clinical evidence, and adaptable deployment options that respect regional regulatory and procurement realities. Decision-makers should therefore evaluate solutions on a composite of clinical validity, deployment flexibility, and post-market support to ensure sustained impact.

Looking ahead, the vendors and providers that win will be those who translate technical accuracy into measurable improvements in workflow efficiency, diagnostic consistency, and patient outcomes, supported by pricing and contracting models that lower the threshold for adoption. By aligning product development with the nuanced needs of specialty users, imaging modalities, and regional healthcare systems, stakeholders can realize the promise of detection technologies and embed them as reliable components of modern diagnostic pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of deep learning algorithms for early lung cancer detection in low-dose CT scanning systems
  • 5.2. Integration of cloud-based computer aided detection platforms for remote radiology collaboration
  • 5.3. Implementation of edge computing solutions to enable real-time image analysis in medical devices
  • 5.4. Expansion of synthetic data and generative adversarial networks to enhance model training datasets
  • 5.5. Emergence of reimbursement frameworks and regulatory pathways for autonomous diagnostic software
  • 5.6. Strategies for mitigating algorithmic bias and ensuring fairness in AI driven medical imaging tools
  • 5.7. Partnership between computer aided detection vendors and electronic health record providers for seamless clinical workflow integration

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Computer Aided Detection Market, by Deployment

  • 8.1. Cloud
    • 8.1.1. Paas
    • 8.1.2. Saas
  • 8.2. On Premise
    • 8.2.1. Perpetual
    • 8.2.2. Subscription

9. Computer Aided Detection Market, by End User

  • 9.1. Diagnostic Centers
  • 9.2. Hospitals
    • 9.2.1. Oncology
    • 9.2.2. Radiology
  • 9.3. Research Labs

10. Computer Aided Detection Market, by Component

  • 10.1. Hardware
  • 10.2. Services
  • 10.3. Software
    • 10.3.1. Algorithm
      • 10.3.1.1. Deep Learning
      • 10.3.1.2. Machine Learning
      • 10.3.1.3. Rule Based

11. Computer Aided Detection Market, by Imaging Modality

  • 11.1. Ct
  • 11.2. Mri
  • 11.3. Pet
  • 11.4. Ultrasound
  • 11.5. X Ray

12. Computer Aided Detection Market, by Application

  • 12.1. Breast Cancer
  • 12.2. Colorectal
  • 12.3. Lung
  • 12.4. Prostate

13. Computer Aided Detection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Computer Aided Detection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Computer Aided Detection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Hologic, Inc.
    • 16.3.2. GE HealthCare Technologies, LLC
    • 16.3.3. Siemens Healthineers AG
    • 16.3.4. Koninklijke Philips N.V.
    • 16.3.5. Fujifilm Holdings Corporation
    • 16.3.6. International Business Machines Corporation
    • 16.3.7. iCAD, Inc.
    • 16.3.8. Volpara Health Technologies Limited
    • 16.3.9. ScreenPoint Medical B.V.
    • 16.3.10. Lunit Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. COMPUTER AIDED DETECTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. COMPUTER AIDED DETECTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COMPUTER AIDED DETECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PAAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SAAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PERPETUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SUBSCRIPTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RESEARCH LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY RULE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY LUNG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY PROSTATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY ALGORITHM, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLIO